Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?

(2020) Frits I. Mulder et al.   Cancers

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

(2019) Tzu‐Fei Wang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

(2018) Andrew J. Lloyd et al.   VALUE IN HEALTH

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

(2017) Nick van Es et al.   HAEMATOLOGICA

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

(2017) Nick van Es et al.   HAEMATOLOGICA

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015

(2015) Michael B. Streiff et al.   Journal of the National Comprehensive Cancer Network

Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH

(2014) A. A. Khorana et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

Targeted prophylaxis in cancer: the evidence accumulates

(2012) Alok A. Khorana   Internal and Emergency Medicine

Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

(2012) Jonas Ahlbrecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD